REQUEST A DEMO
Total
USD $0.00
Search more companies

Elvim SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Elvim SIA Profile Updated: February 25, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Elvim SIA is a marketing and distribution company focused on medicines and medical products, providing commercialization and supply services for healthcare manufacturers and partners. The company supports distribution across the Baltic States and additional export markets, combining market access capabilities with logistics and warehousing infrastructure to serve pharmacies and hospitals. Elvim positions its offer around long-term sector experience, regulatory-aware distribution processes, and broad customer reach through established relationships across healthcare channels, enabling manufacturers to expand coverage and maintain reliable product availability in served markets.

Headquarters
Kurzemes prospekts 3G
Riga; Riga; Postal Code: 1067

Contact Details: Purchase the Elvim SIA report to view the information.

Website: http://www.elvim.lv

Basic Information
Total Employees:
Purchase the Elvim SIA report to view the information.
Registered Capital:
Purchase the Elvim SIA report to view the information.
Financial Auditors:
Purchase the Elvim SIA report to view the information.
Incorporation Date:
February 19, 1992
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
66.67%
Purchase this report to view the information.
33.33%
Subsidiaries
UAB Ameita (Lithuania)
Company Performance
Financial values in the chart are available after Elvim SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-0.65%
Total operating revenue
-0.62%
Operating Profit/Loss (EBIT)
-54.26%
EBITDA
-54.26%
Net Profit/Loss for the Period
-39.4%
Total Assets
19.7%
Total Equity
3.68%
Operating Profit Margin (ROS)
-2.58%
Net Profit Margin
-2%
Return on Equity (ROE)
-4.93%
Quick Ratio
-0.79%
Cash Ratio
-0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?